Motif

Excess weight almost doubles risk of womb cancer

  • 20 April 2022
New research shows that lifelong excess weight almost doubles a woman’s risk of developing womb cancer, according to a Cancer Research UK-funded study led by the University of Bristol and published on 19 April in BMC Medicine. The study from the University of Bristol is one of the first to…

Tracking the rise in prescribing for anxiety in UK primary care

  • 22 March 2022
An increase in medication prescriptions for anxiety between 2003-2018 has been uncovered by new research from the University of Bristol. This increase is thought to be a result of new patients starting treatment, rather than increases in long-term use. Better detection of anxiety and patients being more accepting of medication…

Cochrane review published on 1p19q detection in glioma

  • 8 March 2022
University of Bristol researchers have contributed to an NIHR funded update to the Cochrane review on 1p19q detection in glioma, which has just been published. Gliomas are a type of brain tumour (cancer). There are different types of glioma, with different changes in their genetic material. One of the…

New study of 46 million adults in England confirms blood clot risk with COVID-19 vaccine is very small

  • 22 February 2022
A new study confirms that the risk of blood clots after COVID-19 vaccinations is very low. It showed that people vaccinated with Oxford-AstraZeneca or Pfizer-BioNTech had a lower risk of all venous clots (such as deep vein thrombosis and pulmonary embolism) and all arterial clots (such as strokes and heart…

Regular exercise reduces the risk of and death from pneumonia, study suggests

  • 7 December 2021
People who exercise regularly can reduce their risk of developing and dying from pneumonia, new research has found.  The study, led by researcher the University of Bristol, and funded by the National Institute for Health Research, Bristol Biomedical Research Centre (NIHR Bristol BRC) analysed, for the first time, ten population…

Using Omega-3 fatty acids for the treatment of major depressive disorder in adults

  • 1 December 2021
Researchers from the National Institute for Health Research Bristol Biomedical Research Centre (NIHR Bristol BRC) and the University of Bournemouth have investigated the use of omega-3 fatty acids (n-3PUFAs) as an effective treatment for major depressive disorder (MDD) but found there was no strong evidence to support this. MDD is characterised by depressed mood…

Study aims to understand why COVID-19 vaccines can lead to very rare blood clotting with low platelets

  • 30 November 2021
A group of 11 institutions, led by the University of Liverpool and including National Institute for Health Research Bristol Biomedical Research Centre (NIHR Bristol BRC) researchers at the University of Bristol, is seeking to understand the very rare, but very serious, condition of blood clotting with low platelets in the…

Exploring the effectiveness of a low iodine diet prior to treatment for thyroid cancer

  • 29 November 2021
New research from the National Institute for Health Research Bristol Biomedical Research Centre (NIHR Bristol BRC) says there is no evidence that recommending a low iodine diet for patients two weeks prior to treatment for differentiated thyroid cancer (DTC) as opposed to one week improves treatment success rates. The most effective treatment for thyroid…

How can involvement in research support survivors of domestic abuse?

  • 25 November 2021
Hard Evidence is a theatre piece written and performed by Shass Blake and Alison Prince. It follows the story of two friends, Jan and Christine, who both have experience of domestic abuse, but are at different points in their journey to finding support. It shines light on how involvement in…